Eli Lilly & Co. LLY
$1131.42
+0.55%
at last close
Market Cap$1.00 trillion
P/E Ratio49.30
Div Yield0.61%
Volume4.13M
52-Week Range
$623.78$1166.29
Key Stats
- Today's Range
- $1131.03 – $1166.29
- 50-Day Range
- $850.51 – $1166.29
- 52-Week Range
- $623.78 – $1166.29
- Volume
- 4.13 million shs
- Average Volume
- 3.47 million shs
- Market Cap
- $1.00 trillion
- P/E Ratio
- 49.30
- Dividend Yield
- 0.61%
Valuation
- P/E Ratio
- 49.30
- Price / Book
- 37.82
- Price / Sales
- 15.40
Dividend
- Dividend Yield
- 0.61%
- Annual Dividend
- $6.92
- Payout Ratio
- 30.15%
- Ex-Dividend Date
- 2026-05-15
Short Interest
- Short Interest
- 1.29%
- Days to Cover
- 5.12
Financials (TTM)
- Revenue
- $65.18 billion
- Net Income
- $20.64 billion
- Net Margin
- 31.67%
- Return on Equity
- 77.78%
- Debt-to-Equity
- —
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.